Trial Profile
Outcomes of multiple Dexamethasone injections and conversion to Ranibizumab in patients with retinal vein occlusion macular oedema
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Feb 2018
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary) ; Dexamethasone
- Indications Retinal oedema
- Focus Therapeutic Use
- 19 Feb 2018 New trial record
- 01 Jan 2018 Results published in the Ophthalmologica